{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:52:45Z","timestamp":1791175965658,"version":"4.1.0"},"reference-count":29,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13295","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:21:49Z","timestamp":1789107709000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["A diagnostic and classification model integrating cTnI, CK\u2011MB, MYO and NT\u2011proBNP for cardiovascular diseases"],"prefix":"10.3892","volume":"32","author":[{"given":"Huaxin","family":"Zhang","sequence":"first","affiliation":[{"name":"Clinical Laboratory Department, Beijing Fengtai You'anmen Hospital, Beijing 100069, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Department, Beijing Fengtai You'anmen Hospital, Beijing 100069, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Department, Beijing Fengtai You'anmen Hospital, Beijing 100069, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhi","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Department, Beijing Fengtai You'anmen Hospital, Beijing 100069, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiandong","family":"Chang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Department, Beijing Fengtai You'anmen Hospital, Beijing 100069, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"key20261005073027_b1-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: A scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20261005073027_b2-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","article-title":"Epidemiology of cardiovascular disease in China: Current features and implications","volume":"16","author":"Zhao","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"263","key":"key20261005073027_b3-ETM-32-5-13295","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2010.02.012","article-title":"Cardiovascular disease","volume":"19","author":"Brown","year":"2010","journal-title":"Heart Lung Circ"},{"key":"key20261005073027_b4-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.amepre.2023.11.009","article-title":"Trends in cardiovascular disease mortality rates and excess deaths, 2010-2022","volume":"66","author":"Woodruff","year":"2024","journal-title":"Am J Prev Med"},{"key":"key20261005073027_b5-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"key":"key20261005073027_b6-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1093\/eurheartj\/ehad583","article-title":"Economic burden of cardiovascular diseases in the European Union: A population-based cost study","volume":"44","author":"Luengo-Fernandez","year":"2023","journal-title":"Eur Heart J"},{"key":"key20261005073027_b7-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","article-title":"Epidemiology of cardiovascular disease in young individuals","volume":"15","author":"Andersson","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"key20261005073027_b8-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jamacardio.2022.4887","article-title":"Cardiovascular disease risk prediction in young adults-the next frontier","volume":"8","author":"Khan","year":"2023","journal-title":"JAMA Cardiol"},{"key":"key20261005073027_b9-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamainternmed.2024.2270","article-title":"Routine electrocardiogram screening and cardiovascular disease events in adults","volume":"184","author":"Yagi","year":"2024","journal-title":"JAMA Intern Med"},{"key":"key20261005073027_b10-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamainternmed.2018.2773","article-title":"Screening for cardiovascular disease risk with electrocardiography","volume":"178","author":"Bhatia","year":"2018","journal-title":"JAMA Intern Med"},{"key":"key20261005073027_b11-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/CIRCRESAHA.122.320306","article-title":"Biomedical imaging in experimental models of cardiovascular disease","volume":"130","author":"Sosnovik","year":"2022","journal-title":"Circ Res"},{"issue":"e238178","key":"key20261005073027_b12-ETM-32-5-13295","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-23-8178","article-title":"New Biomarkers for cardiovascular disease","volume":"50","author":"Kim","year":"2023","journal-title":"Tex Heart Inst J"},{"issue":"8208609","key":"key20261005073027_b13-ETM-32-5-13295","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8208609","article-title":"Biomarkers of cardiovascular disease","volume":"2017","author":"Huang","year":"2017","journal-title":"Dis Markers"},{"key":"key20261005073027_b14-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2174\/1570161118999200121143630","article-title":"Novel biomarkers\/predictors of cardiovascular disease and cardiovascular events","volume":"19","author":"Paraskevas","year":"2021","journal-title":"Curr Vasc Pharmacol"},{"key":"key20261005073027_b15-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0025-7753(01)72027-1","article-title":"Hyperuricemia as a cardiovascular risk factor","volume":"117","author":"Garc\u00eda Puig","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"key20261005073027_b16-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14622200020032097","article-title":"Differences among African American light, moderate, and heavy smokers","volume":"3","author":"Okuyemi","year":"2001","journal-title":"Nicotine Tob Res"},{"key":"key20261005073027_b17-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.amjcard.2022.03.001","article-title":"Relation of high-sensitivity cardiac troponin I and obstructive coronary artery disease in patients without acute myocardial infarction","volume":"173","author":"Mohebi","year":"2022","journal-title":"Am J Cardiol"},{"key":"key20261005073027_b18-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/eurheartj\/ehq468","article-title":"Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial","volume":"32","author":"Scirica","year":"2011","journal-title":"Eur Heart J"},{"key":"key20261005073027_b19-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/clc.23425","article-title":"Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy","volume":"43","author":"Liu","year":"2020","journal-title":"Clin Cardiol"},{"key":"key20261005073027_b20-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.amjcard.2013.08.044","article-title":"Usefulness of N-terminal pro-B-type natriuretic Peptide increase as a marker for cardiac arrhythmia in patients with syncope","volume":"113","author":"Costantino","year":"2014","journal-title":"Am J Cardiol"},{"issue":"1467","key":"key20261005073027_b21-ETM-32-5-13295","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.06.117","article-title":"Creatine kinase","volume":"79","author":"Petrou","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"key20261005073027_b22-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0167-5273(03)00105-0","article-title":"Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention","volume":"92","author":"Nageh","year":"2003","journal-title":"Int J Cardiol"},{"key":"key20261005073027_b23-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijcard.2010.06.010","article-title":"Impact of plaque morphology on creatine kinase-MB elevation in patients with elective stent implantation","volume":"146","author":"Yonetsu","year":"2011","journal-title":"Int J Cardiol"},{"key":"key20261005073027_b24-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.hfc.2017.08.004","article-title":"N-Terminal B-type natriuretic peptide in heart failure","volume":"14","author":"Richards","year":"2018","journal-title":"Heart Fail Clin"},{"key":"key20261005073027_b25-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/eurheartj\/ehl233","article-title":"The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation","volume":"27","author":"Shelton","year":"2006","journal-title":"Eur Heart J"},{"key":"key20261005073027_b26-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1134\/S0006297913130063","article-title":"Human cardiac troponin complex. Structure and functions","volume":"78","author":"Katrukha","year":"2013","journal-title":"Biochemistry (Mosc)"},{"key":"key20261005073027_b27-ETM-32-5-13295","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","article-title":"Cardiac troponins: from myocardial infarction to chronic disease","volume":"113","author":"Park","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"945","key":"key20261005073027_b28-ETM-32-5-13295","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-04850-7","article-title":"Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome","volume":"12","author":"Tveit","year":"2022","journal-title":"Sci Rep"},{"issue":"114624","key":"key20261005073027_b29-ETM-32-5-13295","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.114624","article-title":"The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches","volume":"211","author":"Asl","year":"2022","journal-title":"J Pharm Biomed Anal"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:30:33Z","timestamp":1791174633000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,11]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13295","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}